Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
AIMD

AIMD - Ainos, Inc. Stock Price, Fair Value and News

$2.16+0.44 (+25.58%)
Market Closed

39/100

AIMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

39/100

AIMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$1.63

Target 3M

$1.79

Target 6M

$1.74

AIMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AIMD Price Action

Last 7 days

16.8%

Last 30 days

13.7%

Last 90 days

-35.9%

Trailing 12 Months

-41.6%

AIMD RSI Chart

AIMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AIMD Valuation

Market Cap

10.4M

Price/Earnings (Trailing)

-0.7

Price/Sales (Trailing)

91.96

EV/EBITDA

-0.91

Price/Free Cashflow

-2.23

AIMD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$1.63

Target 3M

$1.79

Target 6M

$1.74

AIMD Fundamentals

AIMD Revenue

Revenue (TTM)

113.0K

Rev. Growth (Qtr)

-53.53%

AIMD Earnings

Earnings (TTM)

-15.0M

Earnings Growth (Yr)

20.75%

Earnings Growth (Qtr)

28.23%

AIMD Profitability

Operating Margin

82.69%

EBT Margin

-13231.00%

Return on Equity

-148.9%

Return on Assets

-65.95%

Free Cashflow Yield

-44.84%

AIMD Investor Care

Shares Dilution (1Y)

73.88%

Diluted EPS (TTM)

-3.76

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025106.2K110.9K113.0K0
202493.7K65.1K40.6K20.7K
20232.7M1.8M971.5K122.1K
2022679.6K1.1M2.5M3.5M
2021161.1K305.6K450.1K594.6K
202022.9K22.7K18.1K16.6K
201925.2K25.6K15.4K11.7K
2018307.5K57.3K72.2K77.7K
20170195.9K223.4K250.9K
2016113.4K140.9K168.4K0
201500085.9K
201118.5K31.8K45.1K58.4K
20100005.2K
Get all data in R, Python etc through our Historical Stock Data APIs

About Ainos, Inc.

AIMD
Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.
 CEO
 WEBSITEainos.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES43

Ainos, Inc. Frequently Asked Questions

AIMD is the stock ticker symbol of Ainos, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Ainos, Inc. is 10.4 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check AIMD's fair value in chart for subscribers.

The fair value guage provides a quick view whether AIMD is over valued or under valued. Whether Ainos, Inc. is cheap or expensive depends on the assumptions which impact Ainos, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AIMD.

As of Wed Jan 28 2026, AIMD's PE ratio (Price to Earnings) is -0.7 and Price to Sales (PS) ratio is 91.96. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AIMD PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Ainos, Inc. has provided -0.283 (multiply by 100 for percentage) rate of return.